Dental Journal of Advance Studies

Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2022 ) > List of Articles


Does Smoking and Alcohol Increase the Risk of COVID-19? A Review

Ankit Mahajan, Ujwal Singh

Keywords : COVID-19, SARS-CoV-2, smoking, alcohol, risk

Citation Information : Mahajan A, Singh U. Does Smoking and Alcohol Increase the Risk of COVID-19? A Review. 2022; 10 (2):51-54.

DOI: 10.1055/s-0041-1736490

License: CC BY-NC-ND 4.0

Published Online: 16-11-2021

Copyright Statement:  © 2022. Bhojia Dental College and Hospital affiliated to Himachal


The first case of pneumonia of unknown origin was identified in Wuhan, the capital city of Hubei Province situated in the Republic of China. The pathogenic organism that has been identified as a causative organism is a novel enveloped RNA betacoronavirus, which has been designated as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This virus has been found to have a similar phylogeny to SARS-CoV. The novel coronavirus or COVID-19 can be symptomized through clinical manifestations like pyrexia or fever, cough, dyspnea/difficulty in breathing, myalgia/muscle pain, and constant fatigue. COVID-19 can be transmitted through respiratory tract secretions. It mainly results in respiratory tract infections and the development of severe pneumonia in infected patients. Severe disease may ultimately cause death due to progressive respiratory failure. The coronavirus disease 2019 or COVID-19 has been declared a public health emergency of international proportions by the World Health Organization (WHO). Thus, an analysis of cases might help in the identification of the disease's defining clinical characteristics, association with underlying lifestyle habits, and disease severity. This present article studied the probability of smoking and alcohol consumption in increasing the risk involved in increasing the severity of COVID-19 infection among affected subjects.

PDF Share
  1. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens 2020;9(03): 186–191
  2. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clin Immunol 2020 (e-pub ahead of print). Doi: 10.1016/j.clim.2020.108409
  3. Prevalence of underlying disease in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emergency Med 2020;8(01):235–249
  4. Susceptibility analysis of COVID-19 in smokers based on ACE2. Preprints 2020 (e-pub ahead of print). Doi: 10.20944/preprints202003.0078.V1
  5. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infec 2020;53(03):404–412
  6. CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. AJR Am J Roentgenol 2020;214(06):1287–1294
  7. Relation between chest CT findings and clinical considerations of coronavirus disease (COVID-19) pneumonia: A multicenter study. AJR 2020;4:1–6
  8. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis 2020;18:20–24
  9. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229): 1054–1062
  10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75(07):1730–1741
  11. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med 2020; 75:107–108
  12. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Lancet Public Health 2020;5(05):e259
  13. Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health 1993;83(09):1277–1283
  14. COVID-19: risk of increase in smoking rates among England's 6 million smokers and relapse among England's 11 million ex-smokers. BJGP Open 2021;5(1):bjgpopen21X101161
  15. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020;21(04):e180
  16. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020;104(03):246–251
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.